| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 8.535 | 26.366 | 5.535 | 3.991 | 10.052 | 12.266 |
| Total Income - EUR | - | - | - | - | 14.446 | 41.743 | 9.237 | 6.583 | 11.590 | 14.095 |
| Total Expenses - EUR | - | - | - | - | 10.898 | 48.232 | 7.201 | 3.458 | 18.027 | 13.765 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.548 | -6.489 | 2.035 | 3.125 | -6.437 | 330 |
| Net Profit/Loss - EUR | - | - | - | - | 3.376 | -6.748 | 1.869 | 3.005 | -6.538 | 207 |
| Employees | - | - | - | - | 2 | 2 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Épület Diagnosztika S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 14.811 | 15.345 | 11.303 | 8.747 | 7.195 | 5.638 |
| Current Assets | - | - | - | - | 24.835 | 17.812 | 16.717 | 10.396 | 11.683 | 6.744 |
| Inventories | - | - | - | - | 28 | 583 | 570 | 571 | 569 | 566 |
| Receivables | - | - | - | - | 12.031 | 17.154 | 6.464 | 6.506 | 7.458 | 6.150 |
| Cash | - | - | - | - | 12.776 | 75 | 9.684 | 3.319 | 3.656 | 28 |
| Shareholders Funds | - | - | - | - | 3.418 | -3.310 | -1.368 | 1.633 | -4.910 | -4.675 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 4.624 | 20.791 | 17.761 | 8.438 | 16.280 | 11.419 |
| Income in Advance | - | - | - | - | 31.603 | 15.676 | 11.627 | 9.072 | 7.508 | 5.638 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Épület Diagnosztika S.r.l.